Mathias Oelke - Apr 5, 2022 Form 3 Insider Report for NexImmune, Inc. (NEXI)

Role
Chief Science Officer
Signature
/s/ Ilse Johnson, Attorney-in-fact
Stock symbol
NEXI
Transactions as of
Apr 5, 2022
Transactions value $
$0
Form type
3
Date filed
4/7/2022, 07:10 PM
Next filing
Nov 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEXI Common Stock 7.92K Apr 5, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEXI Stock Option (Right to Buy) Apr 5, 2022 Common Stock 15.8K $2.42 Direct F1
holding NEXI Stock Option (Right to Buy) Apr 5, 2022 Common Stock 47.4K $2.42 Direct F1
holding NEXI Stock Option (Right to Buy) Apr 5, 2022 Common Stock 4.76K $2.58 Direct F1
holding NEXI Stock Option (Right to Buy) Apr 5, 2022 Common Stock 115K $2.58 Direct F1
holding NEXI Stock Option (Right to Buy) Apr 5, 2022 Common Stock 31.9K $4.31 Direct F1
holding NEXI Stock Option (Right to Buy) Apr 5, 2022 Common Stock 19.9K $17.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares underlying this option have vested.
F2 25% of this option vested and became exercisable on February 11, 2022, with the remainder vesting in 36 equal monthly installments thereafter.

Remarks:

Exhibit 24.1 - Power of Attorney